Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03768869Phase 3Withdrawn
A Phase 3 trial of levofloxacin in fever, neutropenia, sponsored by University of Colorado Denver. Planned start Feb 2006; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03768869.